MNI: PBOC Conducts CNY2 Bln Via OMO Tues; Liquidity Unchanged

MNI: PBOC Sets Yuan Parity Lower At 7.1083 Tues; -1.77% Y/Y

CHINA PBOC INJECTS CNY2 BILLION VIA 7-DAY REVERSE REPOS TUES

CHINA SETS YUAN CENTRAL PARITY AT 7.1083 TUES VS 7.1086

MNI China Daily Summary: Monday, June 3

MNI BRIEF: Caixin May Manufacturing PMI Hits Over Two-year High

Core Inflation Softer Than Expected

ECB DataWatch

BoC Data Watch

RPT-MNI: Canada Sticks To Fiscal Anchors, Spends Chunk Of Windfall

MNI BRIEF: Poilievre Calls QE 'Scam' And Would Limit BOC Remit

MNI: Growth Drag From Net Zero Carbon Goal Can Be Offset-OECD

© 1982-2024 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

Markets Remain Concerned Over Vaccine Efficacy Against New Strains (2/2)

GLOBAL
  • UK Government have already said there's no evidence suggesting that UK-approved vaccines will not work against the new B.1.1.7. lineage.
  • The US CDC on Dec19 have said they're evaluating whether the Moderna vaccine is effective against the new strain, but so far everything appears 'okay'.

However, other academics are less sure. Alexandre Le Vert of French vaccine firm Osivax said mutations in surface proteins could even cause some vaccines to exacerbate the infection.

CEO of Emergex vaccines stated their results suggest surface protein-targeting vaccines may not produce an equivalently safe, effective, and long-lived immune response compared to that seen with live attenuated vaccines.

MNI London Bureau | +44 203-865-3809 | edward.hardy@marketnews.com
EM BulletHomepagemarkets-real-timeFixed Income BulletsBulletMarketsEmerging Market NewsForeign Exchange Bullets

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.